Funding Recipients

The Cancer Research Foundation was established to draw attention to the need for cancer research, to provide useful information and resources, and to raise funds for top research facilities across the nation. We consciously support diverse and innovative centers in the expectation that each institute will find a different piece to the puzzle and that, together, will find a cure or cures to the over 200 types of cancer.

Each selected research center has been recognized by their peers for excellence and is ranked as a Comprehensive Cancer Center (conducting programs in all three areas of research: basic research, clinical research, and prevention and control research).

Our recipients for this year are the Mayo Clinic Cancer Center, Memorial Sloan-Kettering Cancer Center, UCLA Jonsson Comprehensive Cancer Center, and UCSF Helen Diller Family Comprehensive Cancer Center.

The Mayo Clinic’s research is focused on developing new and better ways to predict, diagnose, treat and prevent a wide range of cancer. Its innovations span “research bench to bedside,” bringing laboratory discoveries to the care of patients. These discoveries help people not only at the Mayo Clinic but also around the world.

The world’s oldest and largest private cancer center, Memorial Sloan-Kettering Cancer Center (MSKCC) has devoted more than a century to patient care as well as to innovative research, making significant contributions to new and better therapies for the treatment of cancer.

The UCLA Jonsson Comprehensive Cancer Center has established an international reputation for developing new cancer therapies, providing the best in experimental and traditional cancer treatments and expertly guiding and training the next generation of medical researchers. With a membership of more than 240 physicians and scientists, JCCC is one of the largest comprehensive cancer centers in the nation.

Housed within one of the nation’s top biomedical research universities, the UCSF Helen Diller Family Comprehensive Cancer Center consolidates the work of researchers and clinicians who are dedicated to three fundamental pursuits: laboratory research into the causes and events of cancer’s progression; clinical research to translate new knowledge into viable treatments; and population research that can lead to prevention, early detection, and quality-of-life improvement for those living with cancer.